Conditions

Female, 28 years of age, diagnosed with type 1 diabetes at age 25. She was taught to manage her diabetes with a basal/bolus insulin regimen and meal plan prescribed by health care team. She was taught she could eat anything she wanted as long as she covered her carbs with rapid-acting insulin. Her glucose was in control, but she gained 50 pounds over the first year. She then attributed her weight gain to taking insulin, so she would not take enough insulin to cover her glucose levels.

Type 1 indicates the processes of β-cell destruction that may ultimately lead to diabetes in which insulin is required for survival in order to prevent the development of ketoacidosis, coma, and death.

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman, founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles, discuss the ability to predict the development of type 2 diabetes and the role A1c might play in this prediction.

A known link between low testosterone levels and decreased insulin sensitivity could lead to a treatment for men with type 2.

To maintain the benefits while minimizing risk, consider patient risk factors when prescribing, and monitor for DKA and UTI.

Study finds insulin secretion returns to normal with one-gram fat loss.

Study suggests extreme calorie reduction may have same effect as bariatric surgery.

Male, 72 years of age, type 2, insulin requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of work day, glucose elevated much higher than he reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy, leukocyte esterase 2+, wbc >60 H, bacteria many (>50) H, RBC 3-10, H.

A critical requirement for orderly epidemiologic, genetic and clinical research, and indeed for the management of diabetes mellitus and other forms of glucose intolerance is an appropriate classification system. Furthermore, a hallmark in the process of understanding the etiology of a disease and studying its natural history is the ability to identify and differentiate its various forms and place them into a rational etiopathologic framework.

Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association's 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.